Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 Halozyme Therapeuticsbluebird bioCrispr TherapeuticsAllogene TherapeuticsDenali Therapeutics
SymbolNASDAQ:HALONASDAQ:BLUENASDAQ:CRSPNASDAQ:ALLONASDAQ:DNLI
Price Information
Current Price$24.27$63.63$64.58$48.16$27.83
52 Week RangeBuyBuyBuyBuyBuy
Beat the Market™ Rank
Overall Score2.21.61.41.31.2
Analysis Score3.44.43.42.42.4
Community Score2.63.02.52.32.5
Dividend Score0.00.00.00.00.0
Ownership Score3.00.01.02.01.0
Earnings & Valuation Score1.90.60.00.00.0
Analyst Ratings
Consensus RecommendationBuyBuyBuyBuyBuy
Consensus Price Target$28.63$115.47$74.42$42.75$29.80
% Upside from Price Target17.94% upside81.47% upside15.24% upside-11.23% downside7.08% upside
Trade Information
Market Cap$3.19 billion$3.38 billion$3.80 billion$5.83 billion$2.90 billion
Beta1.752.382.261.71.8
Average Volume1,512,6721,803,0681,013,2821,533,238400,017
Sales & Book Value
Annual Revenue$195.99 million$44.67 million$289.59 millionN/A$26.68 million
Price / Sales16.8279.2713.61N/A110.18
CashflowN/AN/A$1.34 per shareN/AN/A
Price / CashN/AN/A48.04N/AN/A
Book Value$0.43 per share$20.13 per share$14.52 per share$4.84 per share$5.16 per share
Price / Book56.443.164.45N/A5.39
Profitability
Net Income$-72,240,000.00$-789,610,000.00$66.86 million$-184,590,000.00$-197,610,000.00
EPS($0.50)($14.31)$1.17($1.83)($2.07)
Trailing P/E RatioN/AN/A86.11N/AN/A
Forward P/E Ratio15.56N/AN/AN/AN/A
P/E GrowthN/AN/AN/AN/AN/A
Net Margins-48.75%-1,531.04%15.73%N/A-825.96%
Return on Equity (ROE)-48.92%-60.05%6.54%-33.05%-46.48%
Return on Assets (ROA)-17.36%-46.17%5.54%-29.27%-34.60%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio6.66%0.16%N/A0.08%0.12%
Current Ratio11.14%5.25%16.87%18.81%12.70%
Quick Ratio10.15%5.25%16.87%18.81%12.70%
Ownership Information
Institutional Ownership Percentage95.37%N/A57.96%57.93%75.03%
Insider Ownership Percentage2.60%3.00%21.40%36.50%21.20%
Miscellaneous
Employees2811,090188122179
Shares Outstanding135.82 million55.65 million61.02 million125.33 million105.63 million
Next Earnings Date8/4/2020 (Estimated)8/6/2020 (Estimated)8/3/2020 (Estimated)8/5/2020 (Estimated)8/4/2020 (Estimated)
OptionableOptionableOptionableOptionableNot OptionableOptionable

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.